Clinuvel Pharmaceuticals Ltd (CLVLY)
10.00
+0.04
(+0.45%)
USD |
OTCM |
Sep 23, 16:00
Clinuvel Pharmaceuticals 1 Year Total Returns (Daily): -0.50% for Sept. 23, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
September 23, 2024 | -0.50% |
September 20, 2024 | -0.60% |
September 19, 2024 | -0.20% |
September 18, 2024 | -4.81% |
September 17, 2024 | -5.09% |
September 16, 2024 | -6.22% |
September 13, 2024 | -6.57% |
September 12, 2024 | -7.67% |
September 11, 2024 | -6.93% |
September 10, 2024 | -11.65% |
September 09, 2024 | -10.73% |
September 06, 2024 | -15.45% |
September 05, 2024 | -16.65% |
September 04, 2024 | -15.90% |
September 03, 2024 | -15.90% |
August 30, 2024 | -19.99% |
August 29, 2024 | -22.25% |
August 28, 2024 | -30.18% |
August 27, 2024 | -30.79% |
August 26, 2024 | -30.72% |
August 23, 2024 | -30.82% |
August 22, 2024 | -32.84% |
August 21, 2024 | -32.24% |
August 20, 2024 | -29.93% |
August 19, 2024 | -32.15% |
Date | Value |
---|---|
August 16, 2024 | -28.96% |
August 15, 2024 | -27.92% |
August 14, 2024 | -25.59% |
August 13, 2024 | -27.08% |
August 12, 2024 | -26.38% |
August 09, 2024 | -20.84% |
August 08, 2024 | -21.44% |
August 07, 2024 | -21.72% |
August 06, 2024 | -16.85% |
August 05, 2024 | -24.06% |
August 02, 2024 | -17.59% |
August 01, 2024 | -20.59% |
July 31, 2024 | -19.03% |
July 30, 2024 | -17.97% |
July 29, 2024 | -18.13% |
July 26, 2024 | -21.59% |
July 25, 2024 | -21.59% |
July 24, 2024 | -21.59% |
July 23, 2024 | -17.87% |
July 22, 2024 | -17.87% |
July 19, 2024 | -20.05% |
July 18, 2024 | -20.31% |
July 17, 2024 | -17.05% |
July 16, 2024 | -15.20% |
July 15, 2024 | -15.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.41%
Minimum
Sep 27 2022
162.3%
Maximum
Mar 18 2021
-3.09%
Average
-14.20%
Median
1 Year Total Returns (Daily) Benchmarks
Alterity Therapeutics Ltd | -53.21% |
Kazia Therapeutics Ltd | -67.53% |
Immutep Ltd | 15.66% |
Opthea Ltd | 129.4% |
Mesoblast Ltd | 171.8% |